What is Darktrace?
Founded in 2013 and headquartered in Cambridge, United Kingdom, Darktrace operates at the intersection of artificial intelligence and cybersecurity. The company provides a sophisticated suite of solutions, including its signature enterprise immune system and antigena cloud technology, designed to autonomously detect and respond to cyber-attack vectors in real-time. By leveraging machine learning to establish a baseline of normal network behavior, Darktrace offers a proactive defense mechanism that adapts to the evolving threat landscape, serving a diverse global clientele across various industries.
How much funding has Darktrace raised?
Darktrace has raised a total of $459.5M across 6 funding rounds:
Series A
$18M
Series B
$22.5M
Series C
$64M
Series D
$75M
Series E
$50M
Share Placement
$230M
Series A (2015): $18M with participation from Hoxton Ventures, Invoke Capital, and Talis Capital
Series B (2015): $22.5M led by Summit Partners
Series C (2016): $64M supported by Summit Partners, Invoke Capital, KKR, SoftBank Corp, and TenEleven Ventures
Series D (2017): $75M featuring Insight Venture Partners, Summit Partners, TenEleven Ventures, and KKR & Co. L.P
Series E (2018): $50M backed by 1011 Ventures, Vitruvian Partners, and KKR
Share Placement (2021): $230M, investors not publicly disclosed
Key Investors in Darktrace
KKR
KKR is a global investment firm investing across private markets in every asset class all over the world, KKR mission is to fortify companies and communities and help secure the futures of the institutions and individuals counting on us.
Summit Partners
Founded in 1984, Summit Partners is an equity investment company that invests in entrepreneurial companies. They are headquartered out of Boston, Massachusetts.
Invoke Capital
Invoke Capital, founded by technologist Mike Lynch, specializes in founding, investing in, and advising fast-growing technology companies in Europe, particularly in artificial intelligence.
What's next for Darktrace?
With the infusion of $230M, Darktrace is well-positioned to accelerate its product development roadmap and deepen its market penetration. The company is expected to focus on enhancing its autonomous response capabilities and expanding its footprint in cloud-native security environments. As the demand for automated, AI-driven security solutions continues to rise, Darktrace's strategic focus will likely remain on scaling its enterprise immune system to address increasingly complex and sophisticated digital threats, ensuring long-term value creation for its stakeholders and partners.
See full Darktrace company page
